info@aurevixpeptides.com
EspañolRead references
Illustrative vial: SermorelinSermorelin

Illustrative presentation

INFORMATIONAL REFERENCE

Sermorelin

Sermorelin is studied through the GHRH pathway that stimulates growth-hormone release. Human endocrine responses help explain its biology, but are not equivalent to demonstrated rejuvenation or fitness benefits.

Research focus & potential applications

GHRH signaling
Endocrine response

What the research shows

Explore the selected studies, their findings and their limits.

Read the findings & sourcesHuman study discussed

An experiment in healthy volunteers compared growth-hormone-releasing factor fragments, including GRF 1–29, and observed increased growth-hormone secretion versus placebo. Sermorelin belongs to this GHRH-fragment approach. A brief endocrine response does not establish improved longevity, sleep, muscle strength or fat loss in otherwise healthy adults.

For more information, contact info@aurevixpeptides.com.

Editorial review: September 23, 2026